BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 31 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,510,653 | +9.1% | 9,600,000 | +11.6% | 0.01% | +7.7% |
| Q2 2023 | $8,715,155 | +16.1% | 8,600,000 | +18.6% | 0.01% | +18.2% |
| Q1 2023 | $7,504,910 | +214.2% | 7,250,000 | +229.5% | 0.01% | +175.0% |
| Q4 2022 | $2,388,408 | +9.3% | 2,200,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,185,000 | -0.0% | 2,200,000 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $2,186,000 | -2.0% | 2,200,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,231,000 | – | 2,200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 32,443,000 | $33,719,632 | 2.49% |
| MACKAY SHIELDS LLC | 76,393,000 | $80,060,298 | 2.20% |
| Lombard Odier Asset Management (Europe) Ltd | 15,560,000 | $16,178,043 | 0.80% |
| Sonora Investment Management Group, LLC | 7,840,000 | $8,152,676 | 0.71% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 25,220,000 | $26,430,712 | 0.50% |
| ZAZOVE ASSOCIATES LLC | 3,750,000 | $3,898 | 0.36% |
| LOOMIS SAYLES & CO L P | 2,059,347 | $200,251 | 0.35% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,332,000 | $1,389,779 | 0.34% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,069 | 0.24% |
| RATIONAL ADVISORS LLC | 1,233,000 | $1,286,026 | 0.10% |